• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传递体:生物活性物质的自我优化载体。

Transfersomes: self-optimizing carriers for bioactives.

作者信息

Rai Kavita, Gupta Yashwant, Jain Anekant, Jain Sanjay K

机构信息

Pharmaceutics Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar-470 003, India.

出版信息

PDA J Pharm Sci Technol. 2008 Sep-Oct;62(5):362-79.

PMID:19055232
Abstract

The transdermal route of drug delivery has gained great interest of pharmaceutical research, as it circumvents number of problems associated with oral route of drug administration. The major barrier in transdermal delivery of drug is the skin intrinsic barrier, the stratum corneum, the outermost envelop of the skin that offers the principal hurdle for diffusion of hydrophilic ionizable bioactives. Recently, various strategies have been used to augment the transdermal delivery of bioactives. Mainly, they include iontophoresis, electrophoresis, sonophoresis, chemical permeation enhancers, microneedles, and vesicular system (liposomes, niosomes, elastic liposomes such as ethosomes and transfersomes). Among these strategies transferosomes appear promising. Transport of this vesicular system through skin and epithelial hurdle depends upon the flexibility of their membrane, which can be attained using appropriate ratio of surfactant. Transfersomes have shown immense potential in drug delivery across the skin. Recent success also demonstrates the potential of transfersome in vaccine, steroid, protein, and peptide delivery across the skin. It is also used for transporting genetic material and achieving transfection. This review highlights the various aspects of the transferosomes in the effective delivery of drug/bioactives across the skin.

摘要

药物经皮给药途径已引起药学研究的极大兴趣,因为它规避了与口服给药途径相关的诸多问题。药物经皮递送的主要障碍是皮肤固有的屏障——角质层,它是皮肤的最外层包膜,为亲水性可电离生物活性物质的扩散提供了主要障碍。最近,人们采用了各种策略来增强生物活性物质的经皮递送。主要包括离子导入法、电泳法、超声导入法、化学渗透促进剂、微针和囊泡系统(脂质体、非离子型脂质体、弹性脂质体如醇质体和传递体)。在这些策略中,传递体似乎很有前景。这种囊泡系统通过皮肤和上皮屏障的转运取决于其膜的柔韧性,这可以通过使用适当比例的表面活性剂来实现。传递体在药物经皮递送方面已显示出巨大潜力。最近的成功也证明了传递体在疫苗、类固醇、蛋白质和肽经皮递送方面的潜力。它还用于运输遗传物质并实现转染。本综述重点介绍了传递体在有效递送药物/生物活性物质经皮方面的各个方面。

相似文献

1
Transfersomes: self-optimizing carriers for bioactives.传递体:生物活性物质的自我优化载体。
PDA J Pharm Sci Technol. 2008 Sep-Oct;62(5):362-79.
2
Vesicular system: Versatile carrier for transdermal delivery of bioactives.囊泡系统:用于生物活性物质经皮递送的多功能载体。
Artif Cells Nanomed Biotechnol. 2015;43(4):282-90. doi: 10.3109/21691401.2014.883401. Epub 2014 Feb 25.
3
A review on skin targeted delivery of bioactives as ultradeformable vesicles: overcoming the penetration problem.关于超可变形囊泡介导生物活性物质皮肤靶向递送:克服渗透问题的综述
Curr Drug Targets. 2014 Feb;15(2):184-98. doi: 10.2174/1389450115666140113100338.
4
Liposomes and skin: from drug delivery to model membranes.脂质体与皮肤:从药物递送 to 模型膜
Eur J Pharm Sci. 2008 Aug 7;34(4-5):203-22. doi: 10.1016/j.ejps.2008.05.002. Epub 2008 May 8.
5
Vesicular carriers for dermal drug delivery.用于皮肤给药的囊泡载体。
Expert Opin Drug Deliv. 2009 Aug;6(8):813-25. doi: 10.1517/17425240903071029.
6
Vesicles: a recently developed novel carrier for enhanced topical drug delivery.囊泡:一种新型载体,可增强局部药物递送。
Curr Drug Deliv. 2014;11(1):87-97. doi: 10.2174/15672018113106660064.
7
Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study.传递体、非离子型脂质体和脂质体中的非侵入性疫苗递送:一项比较研究。
Int J Pharm. 2005 Apr 11;293(1-2):73-82. doi: 10.1016/j.ijpharm.2004.12.022.
8
Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.纳米囊泡与物理方法联合增强模型亲水性药物的透皮递送。
Eur J Pharm Biopharm. 2018 Jun;127:387-397. doi: 10.1016/j.ejpb.2018.03.008. Epub 2018 Mar 23.
9
Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus.纳米囊泡载体作为替代药物传递系统:以醇质体为重点。
Expert Opin Drug Deliv. 2014 Jan;11(1):45-59. doi: 10.1517/17425247.2013.860130. Epub 2013 Dec 3.
10
Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation.作为有效透皮给药载体的醇质体:从实验室到临床应用
Curr Clin Pharmacol. 2016;11(3):168-190. doi: 10.2174/1574884711666160813231352.

引用本文的文献

1
Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications.利用传递体克服皮肤屏障:机遇、挑战与应用
Curr Drug Deliv. 2025;22(2):160-180. doi: 10.2174/0115672018272012231213100535.
2
Fisetin-In Search of Better Bioavailability-From Macro to Nano Modifications: A Review.基于宏观到纳米修饰的研究:寻觅更好生物利用度的非瑟酮-综述。
Int J Mol Sci. 2023 Sep 15;24(18):14158. doi: 10.3390/ijms241814158.
3
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date.
用于神经疾病的脂质基纳米载体:最新技术水平及迄今治疗成功情况综述
Pharmaceutics. 2022 Apr 11;14(4):836. doi: 10.3390/pharmaceutics14040836.
4
Efficacy of Emu Oil Transfersomes for Local Transdermal Delivery of 4-OH Tamoxifen in the Treatment of Breast Cancer.鸸鹋油传递体用于4-羟基他莫昔芬局部透皮给药治疗乳腺癌的疗效
Pharmaceutics. 2020 Aug 25;12(9):807. doi: 10.3390/pharmaceutics12090807.
5
From waste to health: sustainable exploitation of grape pomace seed extract to manufacture antioxidant, regenerative and prebiotic nanovesicles within circular economy.从废物到健康:在循环经济中可持续利用葡萄渣籽油提取物制造抗氧化、再生和益生元纳米囊泡。
Sci Rep. 2020 Aug 25;10(1):14184. doi: 10.1038/s41598-020-71191-8.
6
Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art.传递体作为皮肤癌治疗中通用且灵活的纳米囊泡载体:最新进展
Nano Rev Exp. 2017 Jun 7;8(1):1325708. doi: 10.1080/20022727.2017.1325708. eCollection 2017.
7
Liposomes can both enhance or reduce drugs penetration through the skin.脂质体既能增强也能降低药物经皮渗透。
Sci Rep. 2018 Sep 5;8(1):13253. doi: 10.1038/s41598-018-31693-y.
8
A review on proniosomal drug delivery system for targeted drug action.关于用于靶向药物作用的前体脂质体给药系统的综述。
J Basic Clin Pharm. 2013 Mar;4(2):42-8. doi: 10.4103/0976-0105.113609.
9
DNA vaccines for targeting bacterial infections.用于靶向细菌感染的 DNA 疫苗。
Expert Rev Vaccines. 2010 Jul;9(7):747-63. doi: 10.1586/erv.10.57.
10
Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.脂质纳米粒作为药物载体:从概念到临床。
Crit Rev Ther Drug Carrier Syst. 2009;26(6):523-80. doi: 10.1615/critrevtherdrugcarriersyst.v26.i6.10.